By Peter A. McCullough, MD, MPH
Recently I posted a paper from Choi et al regarding population based hematologic abnormalities in 4.2 million Koreans after COVID-19 vaccination. I wondered if any cases were very serious diagnoses like hematologic malignancies.
Gentilini et al published a case of acute lymphoblastic leukemia in a 38 year old woman with striking symptoms, blood tests, and bone marrow abnormalities after the second dose of the Pfizer/BioNTech Comirnaty mRNA COVID-19 vaccine. One of the clues was how sick the patient became after the second dose:
